Preliminary sentiment and inflation data from the US will offer fresh insight into the tariff impact on household confidence and ultimately the Fed’s policy path.

Although navigating by the stars can seem brave and adventurous, we would not recommend it on financial markets. Better be equipped with a solid compass !

The ECB and Bank of Canada will both announce monetary policy decisions. The tone of President Lagarde’s press conference will be closely monitored for signals on how gradual or front-loaded the path of cuts may be reinforcing a synchronized easing among developed markets - except the Fed.

Global manufacturers are navigating a highly challenging environment marked by tariffs, trade conflicts and new alliances, supply chain disruptions, and rising geopolitical tensions.

Markets will assess the fallout from Donald Trump’s tariff threats on the European Union. The move raises risks for global trade, inflation, and corporate margins.

Over the past twenty-five years, the medical biotechnology sector has profoundly transformed the therapeutic landscape. From the fight against cancer to the development of Covid-19 vaccines in record time, advances in biopharma have changed the outcome for millions of patients worldwide.

Markets will digest the results of the first meeting in three years between Ukraine and Russia, who met in Istanbul.

The global economic cycle is not ending yet – it is reshaping. Following a volatile first quarter and trade escalation at the start of April, May 2025 shows de-escalation amid numerous trade tariff headlines.